P/E ratio for Mesa Laboratories (MLAB)
P/E ratio as of September 2023 (TTM): 344
According to Mesa Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 344.118. At the end of 2021 the company had a P/E ratio of 223.
P/E ratio history for Mesa Laboratories from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 223 | -140.49% |
| 2020 | -551 | |
| 2018 | 76.9 | -156.3% |
| 2017 | -137 | -450.52% |
| 2016 | 39.0 | -5.22% |
| 2015 | 41.1 | 64.34% |
| 2014 | 25.0 | -23.9% |
| 2013 | 32.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 34.3 | -90.03% | 🇺🇸 USA |
 Ametek AME | 28.1 | -91.82% | 🇺🇸 USA |
 General Electric GE | 14.2 | -95.88% | 🇺🇸 USA |
 Danaher DHR | 29.5 | -91.42% | 🇺🇸 USA |
 3M MMM | -35.2 | -110.24% | 🇺🇸 USA |
 Steris STE | 183 | -46.78% | 🇮🇪 Ireland |
 Rockwell Medical
RMTI | -2.16 | -100.63% | 🇺🇸 USA |
 Bruker BRKR | 29.6 | -91.41% | 🇺🇸 USA |
 AngioDynamics ANGO | -5.39 | -101.57% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.